Kilmer CV, 1 of 24

Updated: April 2022

Beau Kilmer 1776 Main Street, P.O. Box 2138, Santa Monica, CA 90407-2138

e: kilmer @ rand dot org p: (310) 393-0411 x6005 twitter: @BeauKilmer EDUCATION

Harvard University, Kennedy School of Government/GSAS, Ph.D. in Public Policy, 2007 University of California—Berkeley, Goldman School of Public Policy, M.P.P., 2000 Michigan State University, James Madison College, B.A. with High Honor, 1998

PROFESSIONAL EXPERIENCE

RAND, McCauley Chair in Drug Policy Innovation, Jan 2021—Present RAND, Director of the RAND Drug Policy Research Center, Aug 2019—Present RAND, Senior Policy Researcher, May 2011—Present RAND, Co-Director of the RAND Drug Policy Research Center, Sept 2008—Aug 2019 RAND, Interim Director of RAND San Francisco Bay Area, Aug 2017—Jan 2018; June 2018—Feb 2019 RAND, Full Policy Researcher, May 2009—May 2011 RAND, Associate Policy Researcher, July 2007—May 2009 RAND, Adjunct Staff, May 1997—October 2003; June 2006—July 2007 National Bureau of Economic Research, Research Assistant, Jan 2004—June 2006 Harvard University, Research Assistant, May 2003—Sept 2003 Superior Court of California, San Francisco, Administrative Analyst, Oct 2001—Aug 2002 Netherlands Institute of Mental Health and Addiction, Visiting Scientist, July 2001 AWARDS & FELLOWSHIPS

Best Article Award, Journal of Benefit-Cost Analysis, 2019. (Shared with Priscillia Hunt &

Jessica Saunders) Distinguished Alumni Award, Oscoda Area High School, 2019 (Inaugural cohort) National Highway Traffic Safety Administration Public Service Award, 2016

“In recognition of your leadership and innovation in the areas of alcohol and drug-impaired driving program and policy research.”

Honourable Mention, Behavioural Exchange Award for Outstanding Research, 2015 Awarded to author(s) of an outstanding piece of research in the behavioural sciences in an applied setting. (Shared with Paul Heaton, Greg Midgette & Nancy Nicosia)

RAND Harold and Colene Brown Faculty Fellowship, 2015 RAND Bronze Merit Bonus Award, 2015 RAND Outreach and Impact Award, 2014 RAND Gold Merit Bonus Award, 2013 (Shared with Rosalie Pacula)

Kilmer CV, 2 of 24

RAND Gulf States Business Development Fellow, 2012 RAND President’s Award, 2011 RAND Gold Merit Bonus Award, 2011 RAND Bronze Merit Bonus Award, 2010 RAND Bronze Merit Bonus Award, 2008 (Shared with Chrissy Eibner) Taubman Center for State and Local Government Research Award, John F. Kennedy School of

Government, Harvard University, 2006-2007 Judicial Administration Fellowship, co-sponsored by the California Judicial Council and the

Center for California Studies at CSU-Sacramento, 2001-2002 Selected to attend the month-long Quantitative Analysis of Crime and Criminal Justice

seminar at ICPSR, University of Michigan, 2000 (Stipend from U.S. Department of Justice) Phi Beta Kappa, 1998 WORKS IN PROGRESS

“Comparing different cannabis law reform policy options using Multi-Criteria Decision

Analysis.” (With C. Wilkins, M. Rychert, T. Decorte, B. Fischer, S. Lenton, & R. Queirolo). Revise and resubmit.

“Do shorter prison sentences influence time to re-arrest?” (With N. Nicosia, E. Thomas, Su.

Bushway, M. Cefalu, & M. Booth). Revise and resubmit. “Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from

the International Cannabis Policy Study.” (With D. Hammond, S. Goodman, E. Wadsworth, T. Freeman, G. Schauer, R. Pacula, W. Hall). Revise and resubmit.

“Experts’ rating of the comparative efficacy of state cannabis policies.” (With J. Blanchette, R.

Pacula, R. Smart, M. Lira, A. Boustead, J. Caulkins, W. Kerr, R. Treffers, & T. Naimi). Revise and resubmit

“Illegally manufactured fentanyl: So much harm, so little known.” (With B. Pardo & J. Taylor).

Under review. “America’s opioid ecosystem: How leveraging system interactions can help curb addiction,

overdose, & other harms.” (Co-edited with B. Stein, J. Taylor, & M. Vaiana). Under review. “How much illegally manufactured fentanyl could the U.S. be consuming? (With B. Pardo, J.

Caulkins, & P. Reuter. Under review. “Comparing two federal financing strategies on penetration and sustainment of the

Adolescent Community Reinforcement Approach for substance use disorders: Protocol for a mixed-method study.” (With A. Dopp, S. Hunter, M. Godley, C. Pham, B. Han, R. Smart, J. Cantor, G. Hindmarch, I. González, L. Passetti, K. Wright, G. Aarons, & J. Purtle). Under review.

Kilmer CV, 3 of 24

“Can alcohol abstinence orders reduce mortality? Insights from an individual-level analysis of 24/7 Sobriety.” (With N. Nicosia & G. Midgette).

“Rapid changes in illegally manufactured fentanyl products and prices.” (With B. Pardo, T.

Pujol-Mitchell, & J. Caulkins). “Illegally manufactured fentanyl: So much harm, so little known.” (With B. Pardo & J. Taylor). “Disentangling the relationship between smoking cessation and psychiatric symptoms:

Evidence from a natural experiment.” (With E. Bloom & N. Nicosia). “Reducing alcohol-related mortality: Insights from an innovative program targeting justice-

involved individuals in North Dakota.” (With B. Pardo, G. Midgette, & N. Nicosia). “Amount of cannabis consumed in New York State: Estimates from a Monte Carlo

simulation.” (With B. Pardo & J. Caulkins). “Relaxing cannabis supply laws & organized crime: A review of the emerging evidence.”

(With J. Taylor & B. Pardo). “Deterring crime in community supervision: Evidence from 24/7 Sobriety.” (With P. Heaton

& N. Nicosia). BOOKS

1. B. Pardo, J. Taylor, J. Caulkins, B. Kilmer, P. Reuter, & B. Stein. (2019). The future of

fentanyl and other synthetic opioids. Santa Monica, CA: RAND.

2. J. Caulkins, B. Kilmer, & M. Kleiman. (2016). Marijuana legalization: What everyone needs to know (2nd edition; significantly revised). New York: Oxford University Press.

J. Caulkins, A. Hawken, B. Kilmer, & M. Kleiman. (2012). Marijuana legalization: What everyone needs to know. New York: Oxford University Press.

JOURNAL PUBLICATIONS

3. B. Kilmer, A. Rivera-Aguirre, R. Queirolo, J. Ramirez, & M. Cerdá. (In press). Cannabis

legalization and traffic injuries: Exploring the role of supply mechanisms. Addiction

4. E. Wadsworth, P. Driezena, R. Pacula, B. Kilmer, & D. Hammond. (In press). Prices and purchase sources for dried cannabis flower in the United States, 2019-2020. Cannabis and Cannabinoid Research

Kilmer CV, 4 of 24

5. C. Firth, K. Warren, L. Perez, B. Kilmer, R. Shih, J. Tucker, E. D’Amico, & E. Pedersen. (In press). Licensed and unlicensed cannabis outlets in Los Angeles County: The potential implications of location for social equity. Journal of Cannabis Research

6. R. Haffajee, B. Kilmer & E. Helland. (2021). Government opioid litigation: The scope of

liability. DePaul Law Review, 70, 275.

7. B. Kilmer, J. Caulkins, M. Kilborn, M. Priest, & K. Warren. (2021). Cannabis legalization and social equity: Some opportunities, puzzles, and tradeoffs. Boston University Law Review, 101, 1003.

8. G. Midgette & B. Kilmer. (2021). Can novel “swift-certain-fair” programs work outside

of pioneering jurisdictions? An analysis of 24/7 Sobriety in Montana, USA. Addiction. https://doi.org/10.1111/add.15584

9. M. Dunbar, N. Nicosia, & B. Kilmer. (2021). Exposure to new smoking environments

and individual-level cigarette smoking behavior: Insights from exogenous assignment of military personnel. Social Science & Medicine, 280, 113983.

10. M. Dunbar, N. Nicosia, & B. Kilmer. (2021). Estimating the impact of state cigarette tax

rates on smoking behavior: Addressing endogeneity using a natural experiment. Drug and Alcohol Dependence, 225, 108807.

11. J. Taylor, A. Ober, B. Kilmer, J. Caulkins, & M. Iguchi. (2021). Community perspectives on

supervised consumption sites: Qualitative insights from four U.S. counties deeply affected by opioids. Journal of Substance Abuse Treatment. https://doi.org/10.1016/j.jsat.2021.108397

12. J. Taylor, B. Pardo, S. Hulme, J. Bouey, V. Greenfield, S. Zhang, & B. Kilmer (2021). Illicit

synthetic opioid consumption in Asia and the Pacific: Assessing the risks of a potential outbreak. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2020.108500

13. B. Pardo, J. Taylor, J. Caulkins, P. Reuter, & B. Kilmer. (2020). The dawn of a new synthetic opioid era: The need for innovative interventions. Addiction. https://doi.org/10.1111/add.15222

14. S. Davenport, M. Robbins, M. Cerda, A. Rivera, & B. Kilmer. (2020). Assessment of the impact of implementation of a zero-blood alcohol concentration law in Uruguay on moderate/severe injury and fatal crashes: A quasi-experimental study. Addiction. https://doi.org/10.1111/add.15231

15. E. Pedersen, C. Firth, A. Rodriguez, R. Shih, R. Seelam, L. Kraus, M. Dunbar, J. Tucker, B.

Kilmer, & E. D’Amico. (2020). Examining associations between licensed and unlicensed outlet density and cannabis outcomes from pre- to post-opening of recreational cannabis outlets. The American Journal on Addictions. https://doi.org/10.1111/ajad.13132

Kilmer CV, 5 of 24

16. S. Heins, J. Caulkins, B. Kilmer, & B. Stein. (2020). Variation in the degree of concentration of prescription opioid utilization using different measures. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2020.108101

17. S. Hunter, M. Tebeka, & B. Kilmer. (2020). Implementing frequent substance use testing with swift-certain-fair sanctions: Stakeholder insights from a pilot program with volunteer probationers. Journal of Drug Policy Analysis. https://doi.org/10.1515/jdpa-2019-0009

18. B. Kilmer & E. Kilmer Neel. (2020). Being thoughtful about cannabis legalization and

social equity. World Psychiatry. https://doi.org/10.1002/wps.20741

19. G. Midgette, B. Kilmer, N. Nicosia, & P. Heaton. (2020). A natural experiment to test the effect of sanction certainty and celerity on substance-impaired driving: North Dakota's 24/7 Sobriety Program. Journal of Quantitative Criminology. https://doi.org/10.1007/s10940-020-09458-6

20. B. Kilmer & G. Midgette. (2020). Criminal deterrence: Insights from an individual-level

analysis of 24/7 Sobriety. Journal of Policy Analysis and Management. https://doi.org/10.1002/pam.22217

21. J. Caulkins, B. Pardo, & B. Kilmer. (2020). Intensity of cannabis use: Findings from three

online surveys. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2020.102740

22. K. Humphreys & B. Kilmer. (2020). Still HOPEful: Discussion of a “failed” replication of the swift, certain, and fair approach to reducing substance use among individuals under criminal justice supervision. Addiction. https://onlinelibrary.wiley.com/doi/full/10.1111/add.15049

23. J. Caulkins, B. Pardo, & B. Kilmer. (2019). Supervised consumption sites: A nuanced

assessment of the causal evidence. Addiction. https://doi.org/10.1111/add.14747 J. Caulkins, B. Pardo, & B. Kilmer. (2019). The benefits of evaluating literatures with essays [Response to Commentaries]. Addiction J. Caulkins, B. Kilmer, B. Pardo. (2019). Disagreeing on whether we agree [Response to Commentary]. Addiction

24. B. Kilmer. (2019). How will cannabis legalization affect health, safety, and social equity outcomes? It depends on the 14Ps. American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2019.1611841

25. B. Kilmer. (2019). Commentary on Bainbridge (2019): Improving the evidence base for 24/7 Sobriety. Addiction. https://doi.org/10.1111/add.14657

26. J. Caulkins, S. Davenport, A. Doanvo, K. Furlong, A. Siddique, M. Turner, & B. Kilmer.

Kilmer CV, 6 of 24

(2019). Triangulating web and general population surveys: How well do results match legal cannabis market sales?” International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2019.06.010

27. B. Kilmer, R. Smart, J. Taylor, & J. Caulkins. (2019). Prescribing diamorphine in the United

States: Insights from a nationally representative survey. Drug and Alcohol Dependence, 196, 62-65.

28. J. Saunders & B. Kilmer. (2019). Changing the narrative: Police-community partnerships and racial reconciliation. Justice Quarterly. DOI: 10.1080/07418825.2019.1568520

29. J. Dilley, S. Richardson, B. Kilmer, R. Pacula, M. Segawa, & M. Cerda. (2019). Prevalence of cannabis use in youths after legalization in Washington state. JAMA Pediatrics, 173, 192-193

30. P. Hunt, J. Saunders, & B. Kilmer. (2019). Estimates of law enforcement costs by crime

type for benefit-cost analyses. Journal of Benefit-Cost Analysis, 10, 95-123.

31. J. Caulkins, Y. Bao, S. Davenport, I. Fahli, Y. Guo, K. Kinnard, M. Najewicz, L. Renaud, & B. Kilmer. (2018). Big data on a big new market: Insights from Washington State’s legal cannabis market. International Journal of Drug Policy, 57, 86-94.

32. L. Giommoni, P. Reuter, & B. Kilmer. (2017). Exploring the perils of cross-national

comparisons of drug prevalence: The effect of survey modality.” Drug and Alcohol Dependence, 181, 194-199

33. B. Kilmer & R. MacCoun. (2017). How medical marijuana smoothed the transition to

marijuana legalization in the United States. Annual Review of Law and Social Science. doi.org/10.1146/annurev-lawsocsci-110615-084851

34. R. Smart, J. Caulkins, B. Kilmer, S. Davenport, & G. Midgette. (2017). Variation in cannabis potency & prices in a newly-legal market: Evidence from 30 million cannabis sales in Washington state. Addiction. doi: 10.1111/add.13886

35. B. Kilmer. (2017). Recreational cannabis—Minimizing the health risks from legalization. The New England Journal of Medicine, 376, 705-707.

36. M. Cerda & B. Kilmer. (2017). Uruguay’s middle-ground approach to cannabis

legalization. International Journal of Drug Policy, 42, 118-120.

37. M. Robbins, J. Saunders, & B. Kilmer. (2017). A framework for synthetic control methods with high dimensional micro-level data: Evaluating a neighborhood-specific crime intervention. Journal of the American Statistical Association, 112, 109-126.

38. B. Kilmer & R. Pacula. (2017). Understanding and learning from the diversification of

cannabis supply laws. Addiction, 112, 1128-1135.

Kilmer CV, 7 of 24

B. Kilmer & R. Pacula. (2017). Building the data infrastructure to evaluate cannabis legalization [Response to Commentaries]. Addiction, 112, 1140-1141.

39. M. Kleiman, B. Kilmer, & A. Hawken. (2017). Desistance mandates compared with treatment mandates for criminally-active substance users under community supervision. Addiction, 112, 748-750.

40. N. Nicosia, B. Kilmer, & P. Heaton. (2016). Can a criminal justice alcohol abstention programme with swift, certain, and moderate sanctions (24/7 Sobriety) reduce population mortality? A retrospective observational study. The Lancet Psychiatry, 3, 226–232.

41. A. Ober, J. Sussell, B. Kilmer, J. Saunders, & D. Heckathorn. (2016). Using respondent-

driven sampling to recruit illegal drug purchasers to evaluate a Drug Market Intervention. Evaluation Review, 40, 87-121.

42. J. Caulkins & B. Kilmer. (2016). Considering marijuana legalization carefully: Insights for

other jurisdictions from an analysis for Vermont. Addiction, 111, 2082-2089. J. Caulkins & B. Kilmer. (2016). The U.S. as an example of how not to legalize marijuana? [Response to Commentaries]. Addiction, 111, 2095-2096.

43. G. Ridgeway & B. Kilmer. (2016). Bayesian inference for the distribution of grams of marijuana in a joint. Drug and Alcohol Dependence, 165, 175-180.

44. B. Kilmer, P. Reuter & L. Giommoni. (2015). What can be learned from cross-national comparisons of data on illegal drugs? Crime and Justice: A Review of Research, 44, 227-296.

45. J. Caulkins, B. Kilmer, P. Reuter, & G. Midgette. (2015). Cocaine’s fall and marijuana’s rise: Questions and insights based on new estimates of consumption and expenditures in U.S. drug markets. Addiction, 110, 728-736. J. Caulkins, B. Kilmer, P. Reuter, & G. Midgette. (2015). Beyond prevalence: Importance of estimating drug consumption and expenditures [Response to Commentaries]. Addiction, 110, 743-745.

46. J. Caulkins, J. Sussell, B. Kilmer, & A. Kasunic. (2015). How much of the cocaine market do we see? Insights from respondent-driven sampling of drug users in a mid-sized American city. Drug and Alcohol Dependence, 147, 190-195.

47. J. Burgdorf & B. Kilmer. (2015). Police costs of the Drug Market Intervention: Insights from two cities. Policing: A Journal of Policy and Practice, 9, 151-163.

48. B. Bond, J. Caulkins, N. Scott, B. Kilmer, & P. Dietze. (2014). Are users’ most recent drug

purchases representative? Drug and Alcohol Dependence, 142, 133-138.

49. B. Kilmer. (2014). Policy designs for cannabis legalization: Starting with the eight Ps.

Kilmer CV, 8 of 24

American Journal of Drug and Alcohol Abuse, 40, 259-261.

50. R. Pacula, B. Kilmer, A. Wagenaar, F. Chaloupka, & J. Caulkins. (2014). Developing public health regulations for marijuana: Lessons from alcohol and tobacco. American Journal of Public Health, 104, 1021-1028.

51. M. Kleiman, B. Kilmer, & D. Fisher. (2014). Theory and evidence on the swift-certain-

fair approach to enforcing conditions of community supervision. Federal Probation, 78.

52. B. Kilmer, N. Nicosia, P. Heaton, & G. Midgette. (2013). Efficacy of frequent monitoring with swift, certain, and modest sanctions for violations: Insights from South Dakota’s 24/7 Sobriety Project. American Journal of Public Health, 103, e37–e43.

53. B. Kilmer & K. Humphreys. (2013). Losing your ‘license to drink’: The radical South

Dakota approach to heavy drinkers who threaten public safety. Brown Journal of World Affairs, 20, 267-277.

54. J. Caulkins, A. Hawken, B. Kilmer, M. Kleiman, K. Pfrommer, J. Pruess, & T. Shaw. (2013).

High tax states: Options for gleaning revenue from legal cannabis. Oregon Law Review, 91, 1042-1067.

55. A. Hawken, J. Caulkins, B. Kilmer, & M. Kleiman. (2013). Quasi-legal cannabis in Colorado and Washington: Local and national implications. Addiction, 108, 837-838.

56. J. Caulkins, S. Everingham, B. Kilmer, & G. Midgette. (2013). The whole is just the sum of its parts: Limited polydrug use among the “big three” expensive drugs in the United States. Current Drug Abuse Reviews, 6, 919-97.

57. R. Burns, J. Caulkins, & S. Everingham, & B. Kilmer. (2013). Statistics on cannabis users

skew perceptions of cannabis use. Frontiers in Psychiatry, 4, 138.

58. J. Caulkins, B. Kilmer, R. Pacula, R. MacCoun, & P. Reuter. (2012). Design considerations for legalizing cannabis: Lessons inspired by analysis of California’s Proposition 19. Addiction, 107, 865–871. J. Caulkins, B. Kilmer, R. Pacula, R. MacCoun, & P. Reuter. (2012). Response to commentaries. Addiction, 107, 866–877.

59. S. Paddock, B. Kilmer, J. Caulkins, M. Booth, & R. Pacula. (2012). An epidemiological model for examining marijuana use over the life course. Epidemiology Research International, 2012, Article ID 520894. doi:10.1155/2012/520894.

60. B. Kilmer, J. Caulkins, R. Pacula, & P. Reuter. (2011). Bringing perspective to illicit markets: Estimating the size of the U.S. marijuana market. Drug and Alcohol Dependence, 119, 153–160.

61. B. Kilmer, J. Burgdorf, E. D’Amico, J. Miles, & J. Tucker. (2011). Multisite cost analysis of a

school-based voluntary alcohol and drug prevention program. Journal of Studies on

Kilmer CV, 9 of 24

Alcohol and Drugs, 72, 823–832.

62. J. Burgdorf, B. Kilmer, & R. Pacula. (2011). Heterogeneity in the composition of marijuana seized in California. Drug and Alcohol Dependence, 117, 59-61.

63. B. Kilmer, C. Eibner, J. Ringel, & R. Pacula (2011). Invisible wounds, visible savings?

Using microsimulation to estimate the costs and savings associated with providing evidence-based treatment for PTSD and depression to veterans of Operation Enduring Freedom and Operation Iraqi Freedom. Psychological Trauma: Theory, Research, Practice, and Policy, 3, 201-211.

64. H. Nunberg, B. Kilmer, R. Pacula, & J. Burgdorf. (2011). An analysis of applicants

presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis. http://www.bepress.com/jdpa/vol4/iss1/art1.

65. R. Pacula, B. Kilmer, M. Grossman, & F. Chaloupka. (2010). Risks and prices: The role of user sanctions in marijuana markets. The B.E. Journal of Economic Analysis & Policy: Vol. 10: Iss. 1 (Contributions), Article 11.

66. M. Kleiman & B. Kilmer. (2009). The dynamics of deterrence. Proceedings of the National

Academy of Sciences of the United States of America, 106, 1420-1423.

67. B. Kilmer. (2008). The future of DIRECT surveillance: Drug and alcohol use Information from REmote and Continuous Testing. Journal of Drug Policy Analysis, 1.

68. B. Kilmer. (2008). Does parolee drug testing influence employment and education outcomes? Evidence from a randomized experiment with noncompliance. Journal of Quantitative Criminology, 24, 93-123.

PEER-REVIEWED RAND REPORTS

69. G. Midgette, S. Davenport, J. Caulkins. & B. Kilmer. (2019). What America’s users spend

on illegal drugs, 2000–2016. RR-3140-ONDCP. Santa Monica, CA: RAND.

70. B. Pardo, J. Caulkins, B. Kilmer, R. Pacula, P. Reuter, & B. Stein. (2019). The synthetic opioid surge in the United States: Insights from mortality and seizure data. RR-3116-RC. Santa Monica, CA: RAND

71. B. Kilmer, S. Davenport, R. Smart, J. Caulkins, & G. Midgette. (2019). After the grand

opening: Assessing cannabis supply and demand in Washington state. RR-3138-WSLCB. Santa Monica, CA: RAND.

72. B. Pardo, B. Kilmer, & W. Huang. (2019). Contemporary Asian drug policy: Insights and

opportunities for change. RR-2733-RC. Santa Monica, CA: RAND.

Kilmer CV, 10 of 24

73. B. Kilmer, J. Taylor, J. Caulkins, P. Mueller, A. Ober, B. Pardo, R. Smart, L. Strang, & P. Reuter. (2018). Considering heroin-assisted treatment & supervised drug consumption sites in the United States. RR-2693-RC. Santa Monica, CA: RAND.

74. B. Pardo, J. Caulkins, & B. Kilmer. (2018) Assessing the evidence on supervised

consumption sites. WR-1261-RC. Santa Monica, CA: RAND. (Some overlap with RR-2693-RC)

75. J. Saunders, A. Ober, B. Kilmer, & S. Greathouse. (2016). A community-based, focused

deterrence approach to closing overt drug markets: A process and fidelity evaluation of seven sites. RR-1001. Santa Monica, CA: RAND.

76. J. Caulkins, B. Kilmer, M. Kleiman, R. MacCoun, G. Midgette, P. Oglesby, R. Pacula, & P.

Reuter. (2015). Considering marijuana legalization: Insights for Vermont and other jurisdictions. RR-864. Santa Monica, CA: RAND.

77. K. Watkins, B. Kilmer, K. Osilla & M. Graf. (2015). Driving under the influence of alcohol:

Could California do more to prevent it? PE-162. Santa Monica, CA: RAND.

78. B. Kilmer & J. Sussell (2014). Does San Francisco’s Community Justice Center reduce criminal recidivism? RR-735. Santa Monica, CA: RAND.

79. B. Kilmer, J. Caulkins, G. Midgette, L. Dahlkemper, R. MacCoun & R. Pacula. (2013). Before

the grand opening: Measuring Washington State’s marijuana market in the last year before legalized commercial sales. RR-466. Santa Monica, CA: RAND.

80. B. Kilmer, J. Caulkins, R. Pacula, & P. Reuter. (2012). The U.S. drug policy landscape:

Insights and opportunities for improving the view. OP-393. Santa Monica, CA: RAND.

81. P. Hunt, B. Kilmer, & J. Rubin. (2011). Development of a European crime report: Improving safety and justice with existing crime and criminal justice data. TR–936–EC. Brussels: RAND.

82. B. Kilmer, J. Caulkins, B. Bond, & P. Reuter. (2010). Reducing drug trafficking revenues

and violence in Mexico: Would legalizing marijuana in California help? OP-325. Santa Monica, CA: RAND.

83. B. Kilmer, J. Caulkins, R. Pacula, R. MacCoun, & P. Reuter. (2010). Altered state? Assessing how marijuana legalization in California could influence marijuana consumption and public budgets. OP-315. Santa Monica, CA: RAND.

84. B. Kilmer & S. Hoorens (Eds.). (2010). Understanding illicit drug markets, supply-reduction efforts, and drug-related crime in the European Union. TR-755-EC. Cambridge, UK: RAND.

85. B. Kilmer & R. Pacula. (2009). Estimating the size of the global drug market: A demand-side approach. TR-711. Santa Monica: RAND.

Kilmer CV, 11 of 24

86. R. Pacula, S. Hoorens, B. Kilmer, P. Reuter, J. Burgdorf, & P. Hunt. (2009). Issues in estimating the economic cost of drug abuse in consuming nations. TR-709. Santa Monica: RAND.

87. P. Reuter, F. Trautmann, R. Pacula, B. Kilmer, A. Gageldonk, & D. van der Gouwe. (2009). Assessing changes in global drug problems, 1998-2007: Main report. TR-704. Santa Monica: RAND.

88. N. Nicosia, R. Pacula, B. Kilmer, R. Lundberg, & J. Chiesa. (2009). The economic cost of

methamphetamine use in the United States, 2005. MG-829. Santa Monica: RAND.

89. R. Davis, J. Rubin, L. Rabinovich, B. Kilmer, & P. Heaton. (2008). A synthesis of literature on the effectiveness of community orders. TR-518. Cambridge: RAND.

90. C. Eibner, J. Ringel, B. Kilmer, R. Pacula, & C. Diaz. (2008). The cost of post-combat

mental health and cognitive conditions. In T. Tanielian & L. Jaycox (Eds.), Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery (pp. 169-242). Santa Monica: RAND.

OTHER REPORTS, BOOK CHAPTERS, & TESTIMONIES

91. J. Dilley, C. Firth, & B. Kilmer. (In press). Cannabis legalization in Washington: Policy

evolution and emerging evidence from the first nine years. In M. Pardal (ed.), Cannabis Social Clubs. Routledge: Oxfordshire UK.

92. J. Caulkins, K. Furlong, B. McComas, M. Nogueira Domingues, A. Siddique & B. Kilmer. (In press). Comparing two approaches for estimating cannabis consumption: Raking and regression. Lisbon: EMCDDA.

93. B. Kilmer. (2020). Reducing barriers & getting creative: 10 federal options to increase treatment access for opioid use disorder & reduce fatal overdoses. Washington DC: Brookings Institution.

94. J. Taylor, L. Strang, K. Kruithof, B. Kilmer, F. Nederveen, E. Disley, L. Wagner, & J. Jehle.

(2020). Comparison of criminal history information systems in the US and five other nations: A review of systems in Australia, Canada, England & Wales, Germany, and the Netherlands. Prepared for the Bureau of Justice Statistics, Washington DC.

95. B. Pardo, B. Kilmer, & R. Pacula. (2020). Monitoring and evaluating changes in cannabis policies: Insights from the Americas. Lisbon: EMCDDA.

96. B. Kilmer, J.P. Caulkins, R.L. DuPont & K. Humphreys. (2019). Reducing substance use in

criminal justice populations. In S. C. Miller, D. A. Fiellin, R. N. Rosenthal, & R. Saitz (Eds.), The ASAM Principles of Addiction Medicine (6th ed., pp. 1768-1783). Philadelphia, PA: Wolters Kluwer.

Kilmer CV, 12 of 24

97. B. Kilmer. (2018). Should Canada “start low and go slow” when it comes to cannabis potency? CT-492. Santa Monica: RAND.

98. B. Kilmer. (2017). New developments in cannabis regulation. Lisbon: EMCDDA.

99. B. Kilmer. (2017). Considering cannabis legalization in Canada: Prices, taxes, and

international implications. CT-481. Santa Monica: RAND.

100. B. Kilmer. (2016). Uncle Sam’s cocaine nosedive: A brief exploration of twelve hypotheses. In J. Collins (Ed.), After the drug wars: Report of the LSE expert group on the economics of drug policy (pp. 67-75). London: London School of Economics and Political Science.

101. B. Kilmer. (2016). Marijuana legalization, government revenues, and public budgets:

Ten factors to consider. CT-449. Santa Monica: RAND.

102. B. Kilmer, G. Midgette, & C. Saloga. (2015). Back in the national spotlight: An assessment of recent changes in drug use and drug policies in the United States. Washington, DC: Brookings.

103. B. Kilmer. (2015). Unprecedented changes in marijuana policy. Britannica Book of the Year 2015 (pp. 250-251). Chicago: Britannica.

104. B. Kilmer, S. Everingham, J. Caulkins, G. Midgette, R. Pacula, P. Reuter, R. Burns, B. Han, & R. Lundberg. (2014). What America’s users spend on illegal drugs, 2000–2010. Prepared for the Office of National Drug Control Policy. Washington, DC: Executive Office of the President. (Peer reviewed)

105. B. Kilmer, K. Kruithof, M. Paradal, J. Caulkins, & J. Rubin (2013). Multinational overview of cannabis production regimes. The Hague: WODC, Ministerie van Veiligheid en Justitie. (Peer reviewed)

106. R. Pacula, R. Lundberg, J. Caulkins, B. Kilmer, S. Greathouse, T. Fain, & P. Steinberg. (2013). Improving the measurement of drug-related crime. Prepared for the Office of National Drug Control Policy. Washington, DC: Executive Office of the President. (Peer reviewed)

107. J. Caulkins & B. Kilmer. (2013). Criminal justice costs of prohibiting marijuana in

California. In K. Tate, J. Taylor, & M. Sawyer (Eds.), Something’s in the air: Race and the legalization of marijuana (pp. 13-30). New York: Routledge.

108. B. Kilmer, J. Taylor, P. Hunt, & P. McGee. (2013). Sizing national heroin markets in the

EU: insights from self–reported expenditures in the Czech Republic and England. In F. Trautman, B. Kilmer, & P. Turnbull (Eds.), Further insights into aspects of the illicit EU drugs market (pp. 257-270). Luxembourg: Publications Office of the European Union. (Peer reviewed)

Kilmer CV, 13 of 24

109. J. Caulkins & B. Kilmer (with M. Graf). (2013). Estimating the size of the EU cannabis market. In F. Trautman, B. Kilmer, & P. Turnbull (Eds.), Further insights into aspects of the illicit EU drugs market (pp. 289-322). Luxembourg: Publications Office of the European Union. (Peer reviewed)

110. A. Villaveces, J. Taylor, & B. Kilmer. (2013). Opioid consumption and substitution

treatment in Finland and Sweden: A similar path with different outcomes? In F. Trautman, B. Kilmer, & P. Turnbull (Eds.), Further insights into aspects of the illicit EU drugs market (pp. 325-344). Luxembourg: Publications Office of the European Union. (Peer reviewed)

111. B. Kilmer & J. Burgdorf. (2013). Insights about cannabis production and distribution

costs in the EU. In F. Trautman, B. Kilmer, & P. Turnbull (Eds.), Further insights into aspects of the illicit EU drugs market (pp. 389-404). Luxembourg: Publications Office of the European Union. (Peer reviewed)

112. B. Kilmer. (2012). Debunking the mythical numbers about marijuana production in

Mexico and the United States. In E. Zedillo and H. Wheeler (Eds.), Rethinking the “war on drugs” through the US-Mexico prism (pp. 168-175). New Haven, CT: Yale Center for the Study of Globalization.

113. B. Kilmer & R. Pacula. (2010). Preventing drug use. In P. Levine & D. Zimmerman

(Eds.), Targeting investments in children: Fighting poverty when resources are limited (pp. 181-220). Chicago: University of Chicago Press/National Bureau of Economic Research.

114. R. Pacula, R. MacCoun, P. Reuter, J. Chriqui, B. Kilmer, K. Harris, L. Paoli, & C. Schaefer.

(2005). What does it mean to decriminalize marijuana? A cross-national empirical examination. In B. Lindgren & M. Grossman (Eds.), Substance use: Individual behavior, interactions, markets, and politics. JAI Press.

115. B. Kilmer & R. MacCoun. (2004). Public policy on addictive disorders. In R. Coombs (Ed.), Handbook of addictive disorders: A practical guide to diagnosis and treatment (pp. 495-534). New York: Wiley.

116. R. MacCoun, B. Kilmer, & P. Reuter. (2003). Research on drug-crime linkages: The

next generation (Commissioned paper). In Drugs and crime: A research agenda for the 21st Century. National Institute of Justice Special Report. Washington, DC: U.S. Department of Justice. Reprinted in M. Kelley. (2006). Readings on drugs and society: The criminal connection. Boston: Allyn & Bacon.

117. B. Kilmer. (2002). Do cannabis possession laws influence cannabis use? In I. Spruit

(Ed.), Cannabis 2002 report: Technical report of the International Scientific Conference (pp. 119-141). Brussels: Ministry of Public Health of Belgium.

Kilmer CV, 14 of 24

SELECT OP-EDS, COMMENTARIES, & MAGAZINE ARTICLES

118. B. Kilmer & B. Pardo. (2021). Treating supervised drug consumption sites like

cannabis. Philadelphia Inquirer, October 22.

119. B. Pardo & B. Kilmer (2020). Being mindful about changing psychedelic policy in California. Sacramento Bee, November 10.

120. B. Kilmer. (2020). Legalizing pot wont secure coronavirus relief for Pa. Philadelphia Inquirer, August 28.

121. B. Kilmer & G. Midgette. (2020). Revoking the ‘license to drink’: Emerging evidence on mandatory sobriety. Institute for Alcohol Studies Blog, June 26.

122. B. Pardo & B. Kilmer. (2019). Synthetic opioid crisis still growing, often among unwitting users. Axios, October 14.

123. B. Pardo, J. Caulkins, & B. Kilmer. (2019). Treat the fentanyl crisis like a poisoning outbreak. Los Angeles Times, September 1.

124. B. Pardo & B. Kilmer. (2019). China’s ban on fentanyl drugs won’t likely stem America’s opioid crisis. Los Angeles Times, May 22.

125. B. Kilmer & B. Pardo. (2019). Addressing federal conflicts over supervised drug consumption sites. The Hill, March 14.

126. B. Kilmer & M. Kleiman. (2018). Navigating cannabis legalization 2.0. The Hill,

December 4.

127. B. Kilmer & R. Smart. (2018). How will cannabis legalization affect alcohol use? GreenState (The San Francisco Chronicle’s cannabis journalism start-up), February 13.

128. B. Kilmer & R. MacCoun. (2017). Should California drop criminal penalties for drug possession? San Francisco Chronicle, July 23.

129. B. Kilmer & G. Midgette. (2017). Mixed messages: Is cocaine consumption in the U.S. going up or down? Brookings Up-Front, April 28.

130. B. Kilmer. (2017). Trump’s marijuana options. The Hill, January 17.

131. B. Kilmer. (2016). The legal marijuana middle ground. USA Today, November 30.

132. B. Kilmer. (2016). Promises and pitfalls of cannabis taxes. San Francisco Chronicle,

August 19.

133. B. Kilmer. (2016). Should some Californians lose their “license to drink”? San Diego Union-Tribune, July 7.

Kilmer CV, 15 of 24

134. B. Kilmer. (2016). If California legalizes marijuana, consumption will likely increase. But is that a bad thing? Los Angeles Times, May 16.

135. B. Kilmer. (2015). So you want to legalize weed? Newsweek, June 28. Originally published as “The 10 P's of marijuana legalization” Berkeley Review of Latin American Studies, Spring.

136. B. Kilmer (2015). Could you lose your license to drink? CNN, June 23.

137. B. Kilmer. (2014). The U.S. federal government tolerates marijuana legalization. Will it last? Friedrich-Ebert-Stiftung IPG Journal, August 18.

138. B. Kilmer. (2014). Taking a sober look at legalizing marijuana. San Francisco

Chronicle, July 13.

139. R. Pacula & B. Kilmer. (2014). Legalising cannabis is more than just a yes or no decision. The Conversation, May 1.

140. B. Kilmer & J. Caulkins. (2014). Hard drugs demand solid understanding. USA Today, March 8.

141. B. Kilmer. (2014). The feds’ role after legalization. New York Times, January 14.

142. B. Kilmer. (2013). Has U.S. gone further than Netherlands over marijuana? CNN, October 12.

143. B. Kilmer. (2013). New approach to prison and the war on drugs. BBC, August 12.

144. B. Kilmer. (2013). Legalization in the U.S. and crime in Mexico. New York Times, May 22.

145. B. Kilmer. (2013). 7 key questions on marijuana legalization. USA Today, April 25. Reposted on TheHealthCareBlog.com, May 29, 2013.

146. J. Caulkins, A. Hawken, B. Kilmer, & M. Kleiman. (2012). A voter’s guide to legalizing marijuana. The American Interest, Nov-Dec.

147. M. Kleiman, J. Caulkins, A. Hawken, & B. Kilmer. (2012). Eight questions for drug policy research. Issues in Science and Technology, Summer.

148. B. Kilmer. (2012). The marijuana exception. The Wall Street Journal, April 21.

149. B. Kilmer. (2011). Mitos de la mota. Nexos, September.

150. B. Kilmer & P. Reuter. (2009). Doped: How two plants wreak havoc on the countries

that produce and consume them — and everyone in between. Foreign Policy, 175, 34-35.

Kilmer CV, 16 of 24

For additional sources, see http://www.foreignpolicy.com/articles/2009/10/19/prime_numbers_doped?page=0,2

151. L. Campos, S. Jimenez, B. Kilmer, A. Knowles, A. Vorobets, & M. Wolf. (2002). Protecting victims of abuse. Los Angeles Daily Journal, September 4.

152. B. Kilmer. (1997). Are needle exchanges a forgotten weapon in the war against AIDS? Los Angeles Times, January 13.

OTHER WRITINGS (SOME DERIVED FROM OTHER PUBLICATIONS)

B. Pardo, J. Taylor, J. Caulkins, B. Kilmer, P. Reuter, & B. Stein. (2019). Understanding America's

surge in fentanyl and other synthetic opioids. RB-10091-RC. Santa Monica, CA: RAND. https://www.rand.org/pubs/research_briefs/RB10091.html

B. Kilmer (2016). Legalized weed: Your questions answered. Newsweek, September 18. http://www.newsweek.com/legalized-weed-your-questions-answered-498861 B. Kilmer. (2016). Is legal weed a net benefit or cost to public health? Newsweek, June 12.

http://www.newsweek.com/legal-grass-net-benefit-cost-public-health-468021 B. Kilmer. (2016). It would be wise to consider middle-ground options. Brookings FixGov Blog,

April 20. http://www.brookings.edu/blogs/fixgov/posts/2016/04/20-critical-issues-in-the-marijuana-policy-debate-hudak

J. Caulkins, B. Kilmer, M. Kleiman, R. MacCoun, G. Midgette, P. Oglesby, R. Pacula, & P. Reuter.

(2015). Options and Issues Regarding Marijuana Legalization. PE-149-RC. Santa Monica, CA: RAND http://www.rand.org/pubs/perspectives/PE149.html

J. Caulkins, B. Kilmer, M. Kleiman, R. MacCoun, G. Midgette, P. Oglesby, R. Pacula, & P. Reuter.

(2015). The Marijuana Legalization Debate: Insights for Vermont. RAND Research Brief, 9825. Santa Monica, CA: RAND. http://www.rand.org/pubs/research_briefs/RB9825.html

B. Kilmer, S. Everingham, J. Caulkins, G. Midgette, R. Pacula, P. Reuter, R. Burns, B.Han, & R.

Lundberg. (2014). How big is the U.S. market for illegal drugs? RAND Research Brief, 9770. Santa Monica: RAND. http://www.rand.org/pubs/research_briefs/RB9770.html

B. Kilmer, N. Nicosia, P. Heaton, & G. Midgette. (2012). An innovative way to curb problem

drinking: South Dakota's 24/7 Sobriety Project. RAND Research Brief, 9692. Santa Monica: RAND. http://www.rand.org/pubs/research_briefs/RB9692.html

B. Kilmer & J. Caulkins. (2010). Filtering through the smoke: Legalizing marijuana would slash

its price, but the effects on use and revenues are hazy. RAND Review, 34: 12-13. B. Kilmer, S. Hoorens, & J. Caulkins. (2010). Do drug arrests work? Measuring the effectiveness

of drug enforcement in Europe. RAND Review, 34: 14-15.

Kilmer CV, 17 of 24

Q&A: Beau Kilmer on President’s National Drug Control Strategy. (2009). Harvard Kennedy School Webpage. http://www.hks.harvard.edu/news-events/news/articles/ash-kilmer-drug-policy-sept09

B. Kilmer. (2009). The indirect consequences of DIRECT surveillance: Drug and alcohol use

Information from REmote and Continuous Testing. The Voice: The National Partnership on Alcohol Misuse and Crime’s quarterly newsletter. http://www.alcoholandcrime.org/npamc/news-events/the-voice/original6

B. Kilmer & M. Iguchi. (2009). Drug treatment for drug-abusing criminal offenders: Insights

from California’s Proposition 36 and Arizona’s Proposition 200. Knowledge Asset, Web site created by the Robert Wood Johnson Foundation's Substance Abuse Policy Research Program. http://www.saprp.org/KnowledgeAssets/Knowledge_Detail.cfm?KAID=17 (Peer reviewed)

Revised “Seizure of Drugs” entry for the third edition of Encyclopedia of Drugs, Alcohol &

Addictive Behavior (MacMillan Reference Books, 2009). H. Rigter, M. van Laar, S. Rigter, & B. Kilmer. (2003). Cannabis: Feiten En Cijfers Anno 2003

(Cannabis: Facts and Figures Year 2003). Utrecht: Bureau Nationale Drugmonitor. P. Ebener & B. Kilmer. (2003). Linking drug users with treatment: Admissions counselors

describe the barriers. RAND Draft Report DRU-2948-PH. R. Pacula & B. Kilmer. (2003). Marijuana and crime: Is there a connection beyond

prohibition? National Bureau of Economic Research Working Paper #10046. RECENT GRANTS, CONTRACTS, & SUBCONTRACTS (as PI or Co-PI)

Z. Cooper (Co-PI) & B. Kilmer (Co-PI). $1,080,000. Assessing the feasibility and

consequences of implementing a cannabis potency tax in California. California Bureau of Cannabis Control. 2021-2023.

B. Kilmer (Co-PI) & S. Hunter (Co-PI). $130,000. Facilitating the San Francisco Street-level

Drug Dealing Task Force. City and County of San Francisco. Subcontractor to LISC. 2020-2021.

B. Kilmer (Co-PI) & B. Pardo (Co-PI). $148,000. Diffusing the fentanyl timebomb in the Asia-

Pacific region. RAND Center for Global Risk and Security. 2020-2021. B. Kilmer (PI). $250,000. Dynamics of cannabis market environment changes and public

health effects after legalization. Subcontractor to Multnomah County. 2R01DA039293-04. 2020-2024.

B. Kilmer (Co-PI), R. Pacula (Co-PI), & B. Stein (Co-PI). $1,500,000. Stemming the tide of the

opioid crisis. RAND Supported Research. 2018-2020.

Kilmer CV, 18 of 24

B. Kilmer (PI). $65,000. Cannabis legalization and social equity. Commonwealth of Virginia. Subcontractor to MPG. 2020.

B. Kilmer (PI). $35,000. Impact of cannabis legalisation on organised crime. Australian

Institute of Criminology. 2019. B. Kilmer (Co-PI), R. Pacula (Co-PI), & B. Stein (Co-PI). $300,000. Improving access to opioid

treatment in two states. Pew Charitable Trusts. 2018-2019. B. Kilmer (PI). $140,000. Subcontractor to New York Univeristy to conduct cannabis

analyses for New York State. 2018-2019. B. Kilmer (PI). $96,000. Subcontractor to BOTEC Analysis Corp to provide marijuana

consumption estimates for the Washington State Liquor Control Board. 2018. B. Kilmer (PI). €25,000. A review of changes in cannabis policies in the Americas. European

Monitoring Centre for Drugs and Drug Addiction. 2018. B. Kilmer (PI) & J. Taylor (Co-PI). $250,000. New ideas for reducing opioid-related deaths,

disabilities & disparities: RAND Supported Research. 2017-2018 B. Kilmer (PI). $68,000. Understanding the drug policy landscape in Asia and prospects for

change. RAND Center for Asia Pacific Policy. 2017-2018. B. Kilmer (PI) & G. Midgette (Co-PI). $408,000. Estimating what America’s users spend on

illegal drugs. White House Office of National Drug Control Policy. 2017-2018. B. Kilmer (PI). $400,000. Comparisons of criminal history information systems in the United

States and other nations. Bureau of Justice Statistics. 2017-2018. N. Nicosia (PI) & B. Kilmer (Co-PI). $785,000. Public health consequences of the 24/7

Sobriety program: A focus on mortality. National Institute on Alcohol Abuse and Alcoholism. 2016-2018. (R01AA024296)

B. Kilmer. $180,000. Health and social consequences of national marijuana legalization

(Uruguay). Subcontractor to University of California, Davis on R01DA040924. 2016-2020. B. Kilmer & G. Midgette. $225,000. Public health and safety impacts of marijuana legalization

in the Pacific Northwest. Subcontractor to Multnomah County on R01DA039293. 2016-2018.

B. Kilmer (PI). $460,000. Can South Dakota's innovative 24/7 Sobriety Program work

outside South Dakota? National Institute on Alcohol Abuse and Alcoholism. 2014-2016. (R21AA022439)

B. Kilmer (PI). $123,000. Assessing marijuana legalization in Vermont. GiveWell/Good Ventures ($103,000) and State of Vermont ($20,000). 2014-2015.

Kilmer CV, 19 of 24

B. Kilmer (PI) & N. Nicosia (Co-PI). $1.1 million. Evaluating South Dakota's 24/7 Sobriety Program. National Institute on Alcohol Abuse and Alcoholism. 2011-2014. (R01AA020074)

G. Ridgeway (PI), B. Kilmer (Co-PI), & J. Saunders (Co-PI). $2.9 million. An evaluation of the

BJA Drug Market Initiative Training and Technical Assistance Initiative. National Institute of Justice. 2011-2014.

B. Kilmer (PI). $66,000. International stocktaking of legal systems for cannabis production.

Wetenschappelijk Onderzoek- en Documentatiecentrum, Ministerie van Veiligheid en Justitie (Dutch Ministry of Secruity and Justice). 2013.

B. Kilmer (PI). $112,000. Subcontractor to BOTEC Analysis Corp to provide marijuana

consumption estimates to the Washington State Liquor Control Board. 2013. B. Kilmer (PI) & S. Everingham (Co-PI). $479,000. Estimating what America’s users spend

on illegal drugs. White House Office of National Drug Control Policy. 2012-2013. B. Kilmer (PI). $25,000. Assessing the drug policy landscape in the United States and

abroad. MacArthur Foundation. 2012. B. Kilmer (PI). $200,000. Evaluating San Francisco’s Community Justice Center. City and

County of San Francisco, Office of the Controller. 2011-2013. F. Trautmann (PI), B. Kilmer (Co-PI), & P. Turnbull (Co-PI). $887,000. Further analysis of the

EU illicit drugs market and responses to it – responding to future challenges. European Commission. 2011-2013.

R. Pacula (PI) & B. Kilmer (Co-PI). $220,000. Measuring drug-related crime. White House Office of National Drug Control Policy. 2011-2012. R. Pacula (PI) & B. Kilmer (Co-PI). $276,000. The effect of NPLEx on methamphetamine production and consumption. Consumer Healthcare Products Association. 2010-2011. E. D’Amico (PI) & B. Kilmer (Co-PI). $255,000. A cost-effectiveness supplement to E.

D’Amico’s parent grant to experimentally evaluate a voluntary brief voluntary alcohol and drug intervention for middle school youth. National Institute on Alcohol Abuse and Alcoholism. 2009-2011.

N. Nicosia (PI) & B. Kilmer (Co-PI). $400,000. The effectiveness of drug treatment to

improve community-level health and social outcomes in California. Robert Wood Johnson Foundation. 2008-2011.

J. Rubin (PI) & B. Kilmer (Co-PI). $195,000. Developing a European Crime Report. European

Commission. 2009-2010. B. Kilmer (PI) & S. Hoorens (Co-PI). $220,000. Study on policy relevant information and

Kilmer CV, 20 of 24

data in the field of drug supply reduction and drug-related crime in the EU and Third Countries. European Commission. 2008-2009.

SELECTED PRESENTATIONS AND ROUNDTABLE DISCUSSIONS

Addiction Health Services Research (2015) Adolescent Early Intervention and SUD Treatment Summit (2017) American Association of Geographers (2016) American Enterprise Institute (2012, 2021) American Medical Association (2021) American Psychological Association (2014) American Society of Criminology (2004, 2005, 2010, 2011, 2013, 2014) American Society of Addiction Medicine (2018) American Society of Health Economists (2012, 2014, 2016) Assessing and Monitoring Marijuana Legalization (Montevideo 2014) Association of Public Health Laboratories (2014) Association of Public Policy and Management (2005-06, 2008-discussant, 2009-12, 2014- moderator, 2015-16) Associação Brasileira do Estudo do Álcool e Outras Drogas (2017) Attorney General Alliance (2020) Australasian Drug & Alcohol Strategy Conference (2015) Australian Drug Foundation (2016) Australian Capital Territory Legislative Assembly Reception (2013, 2017) Australian Professional Society on Alcohol and other Drugs (2015) Behavioural Insights Team (London 2016) Boston University (2018, 2020) Brookings Institution (2012, 2014, 2015, 2017, 2020) Brown University (2012) California Association of Probation Services Administrators (2017) California Society of Addiction Medicine (2011, 2016, 2018, 2020) California State Association of Counties (2015) Canadian Institutes of Health Research Best Brains Exchange (2016) Canberra Drug Policy Series (2019) Cannabis and Youth Symposium (Toronto 2017) Cannabis in Polynesia (2021) Cannabis Science and Policy Summit (2016) Cato Institute (2019) Cedars-Sinai (2015) Charles Drew University of Medicine and Science (2009, 2016) Commonwealth Club (2010) Council of State Governments (2021) Council of the European Union, Horizontal Working Party on Drugs (Brussels 2009) Dartmouth University (2021) Deakin University (Melbourne 2014) Drogas Ilicitas en Colombia (Bogotá 2010-discussant) Duke University (2019)

Kilmer CV, 21 of 24

The Economist’s Cannabis Summit (2019) European Monitoring Center for Drugs and Drug Addiction (2014, 2016, 2020) European Society of Criminology (2014) Future of Medicine Summit (West Palm Beach 2014) Harvard University (2010, 2017) Google (2010, 2017) Guggenheim Symposium on Crime in America at John Jay College (2015) Illicit Trade and Globalisation (Venice, Italy 2008) Informal Expert Dialogue on Cannabis (Punta del Esta 2013) Inter-American Drug Abuse Control Commission of the Organization of American States (2014, 2015) International Conference on Governance, Crime and Justice Statistics (Mexico City 2014; Lima 2018) Interdisciplinary Association for Population Health Science (2018) International Health Economics Association (2013) International Scientific Conference on Cannabis (Brussels 2002) International Society for the Study of Drug Policy (2007-2019) International Society for the Study of Drug Policy webinar (2021) Jonathan Club (2011 x2) Kings College (2018) London School of Economics (2016) Los Angeles County Department of Public Health (2016) Los Angeles Times Festival of Books (2013) Louisiana State Police (2015) Michigan State University (2016) Middlebury College (2016) Mountain Plains ATTC Cannabis Series (2021) National Academy of Sciences, Committee on Law and Justice (2013) National Academy of Sciences, Engineering, and Medicine, Roundtable on the Promotion of Health Equity (2018) National Cannabis Summit (2017, 2019) National Clinician Scholars Program (2018) National Conference on Highway Safety Priorities (2017) National Dialogue about the Future of Drug Policy in Colombia (Bogotá 2014) National District Attorneys Association (2020) National Governors Association (2020) National Network for Safe Communities (2015) National Partnership on Alcohol Misuse and Crime (2009, 2012) New York Academy of Medicine (Albany 2020) New York University (2019) New Zealand Drug Foundation (2015) North Carolina Department of Justice Cannabis Policy Webinar Series (2022) North Dakota Behavioral Health Conference (2014) Organization of American States Workshop on Alternatives to Incarceration (Antigua 2014) RAND Board of Trustees (2010, 2014) RAND Congressional Briefing (2010, 2012, 2015, 2017, 2019) Stanford University (2019)

Kilmer CV, 22 of 24

Symposium on International Drug Control Policy (Hangzhou, China 2015) Universidad de los Andes (2013, 2015) University of Auckland (2019) University of California Berkeley (2014, 2019) University of California Los Angeles (2014, 2018, 2020x2, 2021x2, 2022) University of California San Francisco (2018) University of Colorado Boulder (2018) University of Florida (2014) Universidad Nacional Autónoma de México (2012) University of New South Wales (2013, 2017) University of Oregon (2013) University of Pennsylvania (2014) Western Economic Association (2003, 2006) Winter School (Brisbane, 2019) Workshop on Criminology and the Economics of Crime (2006) World Congress for the Prevention of Addictions in Children and Teenagers (2018) Ventura County Behavioral Health (2016) Vintage Club (2013) Virginia State Bar (2015) World Affairs Council (2014) Yale University (2011) PROFESSIONAL SERVICE

Testimony Nevada Assembly Committee on Growth and Infrastructure, March 28, 2019 Senate of Canada, Standing Committee on Social Affairs, Science, and Technology, May 7, 2018. House of Commons of Canada, Standing Committee on Health, September 14, 2017. Vermont House Committee on Judiciary. March 24, 2016. Vermont Senate Committee on Finance. January 19, 2016. Vermont Legislative Joint Fiscal Committee. November 12, 2014. California State Assembly Public Safety Committee and California State Senate Public Safety

Committee. September 21, 2010. Journal Boards Addiction (Assistant editor, 2009-Present; renamed Associate editor in 2019) Journal of Drug Policy Analysis (Co-editor with M. Kleiman, 2008-2019) Ad-hoc Reviews Journals: Addiction, Alcohol and Alcoholism, American Journal of Public Health, Canadian Medical Association Journal, Contemporary Drug Problems, Crime and Justice, Criminology, Drug and Alcohol Dependence, Drug and Alcohol Review, European Journal of Probation,

Kilmer CV, 23 of 24

International Journal of Drug Policy, International Journal of Offender Therapy and Comparative Criminology, Journal of Applied Economics, Journal of Policy Analysis and Management, Journal of Quantitative Criminology, Journal of Studies on Alcohol and Drugs, Journal of the American Medical Association-Psychiatry, New England Journal of Medicine, Law & Social Inquiry, Prevention Science, Science Funders: National Institutes of Health (NIAAA, NIDA, NCI/CRAN), Social Science Research Council Professional Societies and Committees Member, Council on Criminal Justice (2020-) Panelist, Criminal Justice Expert Panel (2021-) Trustee, International Society for the Study of Drug Policy (2015-2019) Conference committee, International Society for the Study of Drug Policy (2009, 2010, 2015-2019, 2022) Program committee, Association of Public Policy and Management (2016, 2019) Scientific committee, Lisbon Addictions (2017, 2019) Other Affiliations Visiting Scholar, New York University (Marron Institute's Crime and Justice Program; 2016-) Advisor/Consultant (Selected) European Monitoring Centre for Drugs and Drug Addiction Oakland Museum of California National Academy of Sciences’ LabX program, Project Advisory Committee TEACHING EXPERIENCE

Core member of the Pardee RAND Graduate School faculty (2010-) Drugs and Policy. (Pardee RAND Graduate School, 2017) Drugs and Crime. (University of Maryland and People's Police Academy of Vietnam, 2016).

Taught a five-day course in Hanoi as part of the Joint Master’s Degree in Justice Leadership.

Economics of Drug Use and Drug Policy. (Harvard, S2005, Undergraduate). Created tutorial

and taught biweekly seminars for economics majors. Quantitative Analysis and Empirical Methods. (Harvard, F2005, M.P.P.). Teaching Fellow for

Anne Piehl. Dissertation committees: Steve Davenport (Pardee RAND Graduate School), Oliver Hoff

Kilmer CV, 24 of 24

(Université de Genève), Greg Midgette (Pardee RAND Graduate School), Mafalda Pardal (University of Ghent), Bryce Pardo (University of Maryland), Michelle Priest (Pardee RAND Graduate School), Elenore Wadsworth (University of Waterloo)

MEDIA

Select Interviews/Quotes: 1A, Al Jazeera, All Things Considered, AOL News, AOL DailyFinance, Associated Press, Atlantic Monthly, Australian Broadcasting Corporation, BBC News, Bloomberg Businessweek, BNN (Canada), Burlington Free Press, Buzzfeed, CBC Radio, CBS (Sunday Morning, This Morning), CBS Sacramento, CCTV-America, Charlotte Talks, Christian Science Monitor, Chronicle of Higher Education, CNN, CQ Researcher, C-SPAN2, Chicago-Sun Times, Chicago Tribune, Christian Science Monitor, Denver Post, Diane Rehm Show, Dow Jones, Economist, El Espectador (COL), Esquire, Five Thirty Eight, Forbes, Foreign Affairs, Healthline, Huffington Post, International Business Times, KCRW (Olney in L.A., Push Play, To The Point, Which Way, L.A.?), The Globe and Mail, KCBS Radio, KNBC (News Conference), KNPR, KPCC (Air Talk, Take Two), KPIX, KQED (Forum), Le Figaro, Los Angeles Times, The Lund Report, Make Me Smart with Kai & Molly, Marketplace, McClatchy, Milenio, Minnesota Public Radio (The Daily Circuit, MPR News with Angela Davis), Montana Public Radio, Mother Jones, The Nation (US), The Nation (New Zealand), Nature, Netflix (Rotten), New Scientist, New York Times, NBC (Nightly News), New Zealand Herald, NewsHub NZ (The AM Show), NPR, Oakland Tribune, On Point, Pacific Standard, PolitiFact, Portland Press Herald, PRI (The World), Radio Free Europe, Radio New Zealand, Reuters, Rolling Stone, Sacramento Bee, Salon, San Francisco Chronicle, San Jose Mercury, South Bend Tribune, El Tiempo, Time Magazine, Tradeoffs Podcast, Univision, UPI, USA Today, Vermont Public Radio, Vice, Vox, Wall Street Journal, Washington Post (WonkBlog), WHYY (Radio Times), Wired, WNPR (Where We Live), Yahoo Finance